Critical Raw Materials
INFYNITY BIOMARKERS specializes in the design of recombinant proteins and antibodies.
We particularly excel at identifying specific antibody binding sites to support the discovery and development of relevant biomarkers. Using epitope mapping prediction algorithms, our researchers analyze target protein sequences and try to identify the serological hotspots i.e. regions of high immunogenicity allowing them to identify the most promising B-cell epitopes and proprietary sequences.
Optimized Antigen Mixes
Our mixes are composed of carefully selected recombinant proteins and synthetic peptides, designed to enhance detection performance compared with individual antigens.
Advantages
- Well-characterized and tested in RUO assays with well characterized cohorts
- High sensitivity and specificity even during early infection
- Applicable to various instruments and technologies
- Mixes can be provided free, biotinylated or other customized labeling
- Pricing approach adapted to industrial applications
Available mixes include:
- HCV mix: Core, NS3, NS4, NS5
- HIV mix: Gp41, Gp36, and Gp120
- Syphilis mix: Tp15, Tp17, Tp47 and TmpA
- HTLV mix: Gp21, Gp46, P19 (common-type and type-specific)
Monoclonal antibodies for HIV P24 detection
We offer a range of Human monoclonal antibodies detecting different Human immunodeficiency virus P24 epitopes
Key facts
Advantages
| Host species | Human |
| Clonality | Monoclonal |
| Isotype | IgG |
| Reacts with | Human immunodeficiency virus I (HIV-I) P24 protein epitopes |
| Applications | Various immunoassay platforms: ELISA, Rapid Diagnostic Test, Chemiluminescence Immunoassay (CLIA) etc. |

- Human Origin: elimination of human anti-mouse antibodies matrix interference
- Customized labeling: antibodies can be provided free, biotinylated or other labeling
- Lyophilized form: long term stability
- Production standards: produced under a strict quality system
- Track record: Already included in assays of highly regulated countries and peer-reviewed studies (Fratlz et al., 2024)
HIV P24 Antigen Capture Assay
This sandwich ELISA kit quantitatively measures HIV-1 Gag-p24 using a human capture antibody, an HRP-conjugated human detection antibody, and a recombinant P24 standard

Advantages
01
High Performance
Clear diagnostic result
(Detection limit
<10pg/mL* or
<1IU/mL**)
* P24 recombinant protein ** NIBSC standard 90/636
02
Track record
Already included in assays of highly regulated countries and used in peer-reviewed studies (eg. Noailly et al., 2022)
Key facts
| Target | Accurate quantification of HIV-1 P24 antigen |
| Detection | Sandwich ELISA with 450 nm colorimetric readout (universal reader compatibility) |
| Primary utility | Lentivirus titering for cell therapy development |
| Sample versatility | Serum, plasma, culture supernatants, and tissue/cell lysates |
Antigens & Antibodies
Our main products are listed below. For more details, to request a quote, or if you are interested in obtaining a different material, please contact us.









